Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1
Acta Pharmaceutica Sinica B · 2026-11
DOI: 10.1016/j.apsb.2026.11.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Ying Qu und 12 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Province Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Henan Province Natural Science Foundation
Zitieren
APA
Qu, Y., Shen, X., Zhang, C., Hai, R., Li, Z., Lu, J., Lyu, S., Xue, W., Sun, R., Jin, C., Chang, J., Wang, X., & Wang, Z. (2026). Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.003
Vancouver
Qu Y, Shen X, Zhang C, Hai R, Li Z, Lu J, et al. Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.11.003
BibTeX
@article{Qu2026,
author = {Qu, Ying and Shen, Xiaoxiao and Zhang, Chaofeng and Hai, Ruotong and Li, Ziyan and Lu, Jiejie and Lyu, Su and Xue, Wenhua and Sun, Ranran and Jin, Chengyun and Chang, Junbiao and Wang, Xiaona and Wang, Zhenya},
title = {Virus target inhibition and immune enhancement of cyclobutenamine derivatives against herpes simplex virus type 1},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.11.003}
}
EUVIMED